Boston Scientific Corp

$94.82
(as of Apr 4, 9:48 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Boston Scientific Corp

Stock Price
$94.82
Ticker Symbol
BSX
Exchange
NYSE

Industry Information for Boston Scientific Corp

Sector
Healthcare
Industry
Medical Devices

Company Description for Boston Scientific Corp

Country
USA
Full Time Employees
53,000

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Fundamentals for Boston Scientific Corp

Market Capitalization
$147,980,959,744
EBITDA
$4,271,000,064
Dividends per Share
P/E Ratio
80.04
Forward P/E Ratio
35.46
Earnings per Share
$1.25
Earnings per Share Estimate Next Year
Profit Margin
11.07%
Shares Outstanding
1,479,069,952
Percent Owned by Insiders
0.19%
Percent Owned by Institutions
92.98%
52-Week High
52-Week Low

Technical Indicators for Boston Scientific Corp

50-Day Moving Average
200-Day Moving Average
RSI
43.72
2.54

Analyst Ratings for Boston Scientific Corp

Strong Buy
21
Buy
8
Hold
5
Sell
0
Strong Sell
0

News About Boston Scientific Corp

Apr 4, 2025, 5:01 AM EST
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks See more.
Apr 3, 2025, 6:00 PM EST
Boston Scientific (BSX) closed the most recent trading day at $98.50, moving -1.55% from the previous trading session. See more.
Apr 3, 2025, 1:25 PM EST
Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2024. See more.
Apr 3, 2025, 1:13 PM EST
AngioDynamics, Inc. See more.